Tidal Investments’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-50,000
Closed -$522K 1440
2023
Q3
$522K Hold
50,000
0.02% 821
2023
Q2
$513K Buy
50,000
+10,000
+25% +$101K 0.02% 812
2023
Q1
$402K Buy
40,000
+15,388
+63% +$154K 0.01% 872
2022
Q4
$249K Hold
24,612
0.01% 954
2022
Q3
$242K Hold
24,612
0.01% 874
2022
Q2
$241K Buy
24,612
+2,997
+14% +$29.3K 0.01% 905
2022
Q1
$212K Hold
21,615
0.01% 984
2021
Q4
$211K Buy
21,615
+11,205
+108% +$109K 0.01% 899
2021
Q3
$101K Buy
+10,410
New +$101K ﹤0.01% 840

Other funds holding COCH

Tidal Investments's COCH Position: Q4 2023 in Review

Tidal Investments sold out of Envoy Medical (COCH) in Q4 2023, closing a stake of 50,000 shares — an estimated $522K sold.

Tidal Investments first reported a position in COCH in Q3 2021 and held it in 9 quarters. The position peaked at $522K in Q3 2023. 9 funds tracked by Wall St. Rank hold COCH as of Q4 2023.

  • Tidal Investments reported no remaining Envoy Medical position as of Q4 2023 after selling out during the quarter.
  • Tidal Investments sold 50,000 Envoy Medical shares in Q4 2023, an estimated $522K.
  • Tidal Investments first reported a position in Envoy Medical in Q3 2021 and held it in 9 quarters.
  • Tidal Investments's Envoy Medical position peaked at $522K in Q3 2023.
  • 9 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2023.

Based on Tidal Investments's 13F filing for Q4 2023, filed 15 Feb 2024.